Jens Stieler

3.1k total citations
51 papers, 2.1k citations indexed

About

Jens Stieler is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Jens Stieler has authored 51 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 13 papers in Surgery. Recurrent topics in Jens Stieler's work include Pancreatic and Hepatic Oncology Research (35 papers), Cancer Genomics and Diagnostics (11 papers) and Neuroendocrine Tumor Research Advances (10 papers). Jens Stieler is often cited by papers focused on Pancreatic and Hepatic Oncology Research (35 papers), Cancer Genomics and Diagnostics (11 papers) and Neuroendocrine Tumor Research Advances (10 papers). Jens Stieler collaborates with scholars based in Germany, United States and Belgium. Jens Stieler's co-authors include Uwe Pelzer, Helmut Oettle, Hanno Riess, Bernd Dörken, Ingo Schwaner, Marianne Sinn, Jörg Seraphin, Andreas Hilbig, Sven Bischoff and Bernhard Opitz and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Jens Stieler

49 papers receiving 2.0k citations

Peers

Countries citing papers authored by Jens Stieler

Since Specialization

Citations

This map shows the geographic impact of Jens Stieler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Stieler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Stieler more than expected).

Fields of papers citing papers by Jens Stieler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens Stieler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Stieler. The network helps show where Jens Stieler may publish in the future.

Co-authorship network of co-authors of Jens Stieler

This figure shows the co-authorship network connecting the top 25 collaborators of Jens Stieler. A scholar is included among the top collaborators of Jens Stieler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Stieler. Jens Stieler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Alpha synuclein processing by MMP-3 – implications for synucleinopathies 2022 ·Behavioural Brain Research ·(unknown), (unknown), (unknown), Jens Stieler, (unknown), Stephan Schilling, (unknown), Stephan von Hörsten, Maike Hartlage‐Rübsamen, Franziska Richter, Steffen Roßner	4
2	Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemcitabine – Results from the CONKO-001 trial 2015 ·European Journal of Cancer ·M. Sinn, Hanno Riess, (unknown), Jens Stieler, Uwe Pelzer, Jana K. Striefler, Helmut Oettle, Marcus Bahra, Carsten Denkert, Hendrik Bläker, Philipp Lohneis	34
3	Second-Line Treatment in Pancreatic Cancer Patients 2015 ·Pancreas ·Marianne Sinn, (unknown), Jana K. Striefler, Sven Bischoff, Nóra Schweitzer, Uwe Pelzer, Bernd Dörken, Hanno Riess, Jens Stieler	18
4	Intensified chemotherapy and simultaneous treatment with heparin in outpatients with pancreatic cancer – the CONKO 004 pilot trial 2014 ·BMC Cancer ·Uwe Pelzer, Andreas Hilbig, Jens Stieler, Marcus Bahra, Marianne Sinn, Bernhard Gebauer, Bernd Dörken, Hanno Riess	18
5	α-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study 2014 ·British Journal of Cancer ·M. Sinn, Carsten Denkert, Jana K. Striefler, Uwe Pelzer, Jens Stieler, Marcus Bahra, Philipp Lohneis, Bernd Dörken, Helmut Oettle, Hanno Riess, Bruno V. Sinn	112
6	KRAS Mutations in Codon 12 or 13 Are Associated With Worse Prognosis in Pancreatic Ductal Adenocarcinoma 2014 ·Pancreas ·Bruno V. Sinn, Jana K. Striefler, (unknown), Annika Lehmann, Marcus Bahra, Carsten Denkert, Marianne Sinn, Jens Stieler, Frederick Klauschen, Jan Budczies, Wilko Weichert, Albrecht Stenzinger, Carsten Kamphues, Manfred Dietel, Hanno Riess	34
7	SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study 2014 ·Annals of Oncology ·M. Sinn, (unknown), Jana K. Striefler, Judith Lindner, Jens Stieler, Philipp Lohneis, Sven Bischoff, (unknown), Uwe Pelzer, Marcus Bahra, Manfred Dietel, Bernd Dörken, Helmut Oettle, Hanno Riess, Carsten Denkert	63
8	Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy 2013 ·Frontiers in Oncology ·Uwe Pelzer, Andreas Hilbig, Marianne Sinn, Jens Stieler, Marcus Bahra, Bernd Dörken, Hanno Riess	26
9	Biliary Tract Cancer: A Survey Regarding the Current Oncological Daily Care Practice in Germany 2012 ·Onkologie ·Marianne Sinn, Sven Bischoff, Oliver Nehls, Uwe Pelzer, Fritz von Weizsäcker, Stefan Kubicka, Jens Stieler, Karel Caca, Hanno Riess	1
10	Long-term survival in patients with pancreatic cancer: Relevant factors in CONKO-001. 2012 ·Journal of Clinical Oncology ·Marianne Sinn, Bruno V. Sinn, (unknown), Jens Stieler, Marco Niedergethmann, Klaus Gellert, P. Neuhaus, Bernd Dörken, Carsten Denkert, Hanno Riess, Helmut Oettle	4
11	First-line treatment of pancreatic cancer patients with the combination of 5-fluorouracil/folinic acid plus gemcitabine: a multicenter phase II trial by the CONKO-study group 2011 ·Cancer Chemotherapy and Pharmacology ·Uwe Pelzer, Dirk Arnold, P Reitzig, (unknown), F.W. Korsten, Manfred Kindler, Jens Stieler, Bernd Dörken, Hanno Riess, Helmut Oettle	5
12	Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: A phase III-study from the German CONKO-study group 2011 ·European Journal of Cancer ·Uwe Pelzer, Ingo Schwaner, Jens Stieler, (unknown), Jörg Seraphin, Bernd Dörken, Hanno Riess, Helmut Oettle	256
13	Parenteral nutrition support for patients with pancreatic cancer. Results of a phase II study 2010 ·BMC Cancer ·Uwe Pelzer, Dirk Arnold, (unknown), Jens Stieler, Bernd Doerken, Hanno Riess, Helmut Oettle	58
14	Surgical results of patients after esophageal resection or extended gastrectomy for cancer of the esophagogastric junction 2009 ·Diseases of the Esophagus ·Guido Schumacher, Samuel Schmidt, (unknown), Thomas Röesch, Matteo Sacchi, Vera von Dossow, Sascha Chopra, Johann Pratschke, (unknown), Jens Stieler, Peter Thuss‐Patience, Philipp Neuhaus	13
15	Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial 2008 ·British Journal of Cancer ·Oliver Nehls, Helmut Oettle, J. T. Hartmann, R. D. Hofheinz, (unknown), Marius Horger, (unknown), Andreas Hochhaus, Jens Stieler, Jörg Trojan, Michael Gregor, Bodo Klump	95
16	Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy) 2008 ·BMC Cancer ·Hanno Riess, Uwe Pelzer, Andreas Hilbig, Jens Stieler, Bernhard Opitz, T Scholten, (unknown), Peter Bramlage, Bernd Dörken, Helmut Oettle	68
17	De Novo Esophageal Neoplasia After Liver Transplantation 2007 ·Liver Transplantation ·(unknown), Guido Schumacher, R. Neuhaus, Peter Thuss‐Patience, Jens Stieler, P. Neuhaus	25
18	Immunotherapeutic Approaches in Pancreatic Cancer 2007 ·PubMed ·Jens Stieler	3
19	Detection of Ki-ras mutations in tissue and plasma samples of patients with pancreatic cancer using PNA-mediated PCR clamping and hybridisation probes 2005 ·British Journal of Cancer ·Jan Däbritz, (unknown), (unknown), Jens Stieler, Helmut Oettle	69
20	Aktuelle Diagnostik und Therapie des fortgeschrittenen Pankreaskarzinoms 2005 ·DMW - Deutsche Medizinische Wochenschrift ·Jens Stieler, Helmut Oettle	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact